Cancer Genetics and Epigenetics 2018, Vol.6, No.4, 25-32
30
Authors’ contributions
ZDW read and approved the final manuscript. LWQ and YM wrote and translated the manuscript. LWQ, YSR, ZJY, ZBZ, and YM
collected materials. All authors read and approved the final manuscript.
Acknowledgments
This work was supported by the Heilongjiang scientific research project (grants 201810).
References
Azzi S., Steunou V., Tost J., et al., 2015, Exhaustive methylation analysis revealed uneven profiles of methylation at IGF2/ICR1/H19 11p15 loci in Russell
Silver syndrome, Journal of Medical Genetics, 52(1): 53-60
Belharazem D., Magdeburg J., Berton A.K., et al., 2016, Carcinoma of the colon and rectum with deregulation of insulin-like growth factor 2 signaling: clinical
and molecular implications, Journal of Gastroenterology, 51(10): 971-984
Ben-Zaken S., Meckel Y., Nemet D., and Eliakim A., 2017, High prevalence of the IGF2 rs680 GG polymorphism among top-level sprinters and jumpers,
Growth Hormone & Igf Research Official Journal of the Growth Hormone Research Society & the International Igf Research Society, 37: 26
Bergman D., Halje M., Nordin M., et al., 2013, Insulin-Like Growth Factor 2 in Development and Disease: AMini-Review, Gerontology, 59(3): 240-249
Callum L., 2013, IGF2 and cancer, Endocrine-related cancer, 20(6): 321-339
Creemers S.G., van Koetsveld P.M., van Kemenade F.J., et al., 2016, Methylation of IGF2 regulatory regions to diagnose adrenocortical carcinomas,
Endocrine-related cancer, 23(9): 727
Dong Y., Li J.J., Han F., Chen H.Q., Zhao X.X., Qin Q., Shi R.H., and Liu J.Y., 2015, High IGF2 expression is associated with poor clinical outcome in human
ovarian cancer, Oncology Reports, 34(2): 936-942
Coto E., Díaz C.C., Tranche S., et al., 2018, Genetic variation in the H19-IGF2 cluster might confer risk of developing impaired renal function, DNA and Cell
Biology, 37(7): 617-625
Espelund U., Cold S., Frystyk J., Orskov H., and Flyvbjerg A., 2008, Elevated free IGF2 levels in localized, early-stage breast cancer in women, European
Journal of Endocrinology, 159(5): 595-601
Hur S.K., Freschi A., Ideraabdullah F., et al., 2016, Humanized H19/Igf2 locus reveals diverged imprinting mechanism between mouse and human and reflects
Silver-Russell syndrome phenotypes, Proceedings of the National Academy of Sciences of the United States of America, 113(39): 10938
PMCid:PMC5047210
Ito Y., Koessler T., Ibrahim A.E.K., et al., 2008, Somatically acquired hypomethylation of IGF2 in breast and colorectal cancer, Human Molecular Genetics,
17(17): 2633-2643
PMCid:PMC2515372
Lahbib-Mansais Y., Barasc H., Marti-Marimon M., Mompart F., Lannuccelli E., Robelin D., Riquet J, and Yerle-Bouissou M., 2016, Expressed alleles of
imprinted IGF2, DLK1 and MEG3 colocalize in 3D-preserved nuclei of porcine fetal cells, Bmc Cell Biology, 17(1): 35
PMCid:PMC5045652
Li J., Li P.P., Liu J., Zhou C., and Liu P.J., 2018, The relationship between tumor suppressor LKB1 and tamoxifen resistance of breast cancer, Journal of Modern
Oncology, 26: 3184-3189
Massoner P., Ladurner-Rennau M., Eder I.E., and Klocker H., 2010, Insulin-like growth factors and insulin control a multifunctional signalling network of
significant importance in cancer, British Journal of Cancer, 103(10): 1479-1484
Mishima C., Kagara N., Tanei T., Naoi Y., Shimoda M., Shimomura A., Shimazu K., Kim S.J., and Noguchi S., 2015, Loss of imprinting of IGF2 in
fibroadenomas and phyllodes tumors of the breast, Oncology Reports, 35(3): 1511
PMid:26676988
